Alessandro Zuddas
Title
Cited by
Cited by
Year
Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments
EJS Sonuga-Barke, D Brandeis, S Cortese, D Daley, M Ferrin, ...
American Journal of Psychiatry 170 (3), 275-289, 2013
11792013
Long-acting medications for the hyperkinetic disorders
T Banaschewski, D Coghill, P Santosh, A Zuddas, P Asherson, J Buitelaar, ...
European child & adolescent psychiatry 15 (8), 476-495, 2006
5352006
The quality of life of children with attention deficit/hyperactivity disorder: a systematic review
M Danckaerts, EJS Sonuga-Barke, T Banaschewski, J Buitelaar, ...
European child & adolescent psychiatry 19 (2), 83-105, 2010
5232010
European guidelines on managing adverse effects of medication for ADHD
J Graham, T Banaschewski, J Buitelaar, D Coghill, M Danckaerts, ...
European child & adolescent psychiatry 20 (1), 17-37, 2011
4442011
Cognitive training for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials
S Cortese, M Ferrin, D Brandeis, J Buitelaar, D Daley, RW Dittmann, ...
Journal of the American Academy of Child & Adolescent Psychiatry 54 (3), 164-174, 2015
4392015
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta …
S Cortese, N Adamo, C Del Giovane, C Mohr-Jensen, AJ Hayes, ...
The Lancet Psychiatry 5 (9), 727-738, 2018
4262018
Neurofeedback for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials
S Cortese, M Ferrin, D Brandeis, M Holtmann, P Aggensteiner, D Daley, ...
Journal of the American Academy of Child & Adolescent Psychiatry 55 (6), 444-455, 2016
2322016
Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns
B Vitiello, C Correll, B van Zwieten-Boot, A Zuddas, M Parellada, ...
European Neuropsychopharmacology 19 (9), 629-635, 2009
2302009
Contrasting deficits on executive functions between ADHD and reading disabled children
GM Marzocchi, J Oosterlaan, A Zuddas, P Cavolina, H Geurts, D Redigolo, ...
Journal of Child Psychology and Psychiatry 49 (5), 543-552, 2008
1852008
Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study
D Michelson, JK Buitelaar, M Danckaerts, C Gillberg, TJ Spencer, ...
Journal of the American Academy of Child & Adolescent Psychiatry 43 (7), 896-904, 2004
1842004
Prevalence and correlates of mental disorders among adolescents in Italy: the PrISMA study
A Frigerio, P Rucci, R Goodman, M Ammaniti, O Carlet, P Cavolina, ...
European child & adolescent psychiatry 18 (4), 217-226, 2009
1802009
MK‐801 prevents 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine‐induced parkinsonism in primates
A Zuddas, G Oberto, F Vaglini, F Fascetti, F Fornai, GU Corsini
Journal of neurochemistry 59 (2), 733-739, 1992
1751992
Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: a systematic review and meta-analysis
T Usala, A Clavenna, A Zuddas, M Bonati
European neuropsychopharmacology 18 (1), 62-73, 2008
1482008
The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles
RD Oades, AG Sadile, T Sagvolden, D Viggiano, A Zuddas, P Devoto, ...
Developmental Science 8 (2), 122-131, 2005
1422005
Cardiovascular effects of stimulant and non-stimulant medication for children and adolescents with ADHD: a systematic review and meta-analysis of trials of methylphenidate …
L Hennissen, MJ Bakker, T Banaschewski, S Carucci, D Coghill, ...
CNS drugs 31 (3), 199-215, 2017
1302017
Long-term risperidone for pervasive developmental disorder: efficacy, tolerability, and discontinuation
A Zuddas, A Di Martino, P MUGLIA, C CIANCHETTI
Journal of Child and Adolescent Psychopharmacology 10 (2), 79-90, 2000
1262000
Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studies
A Zuddas, R Zanni, T Usala
European Neuropsychopharmacology 21 (8), 600-620, 2011
1232011
Clinical effects of clozapine on autistic disorder.
A Zuddas, MG Ledda, A Fratta, P Muglia, C Cianchetti
American Psychiatric Assn, 1996
1231996
ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group
S Cortese, P Asherson, E Sonuga-Barke, T Banaschewski, D Brandeis, ...
The Lancet Child & Adolescent Health 4 (6), 412-414, 2020
1192020
European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
D Coghill, T Banaschewski, M Lecendreux, C Soutullo, M Johnson, ...
European Neuropsychopharmacology 23 (10), 1208-1218, 2013
1152013
The system can't perform the operation now. Try again later.
Articles 1–20